How psychotherapy changes the brain – the contribution of functional neuroimaging

[1]  V. van de Ven,et al.  Pain Response in Depersonalization: A Functional Imaging Study Using Hypnosis in Healthy Subjects , 2007, Psychotherapy and Psychosomatics.

[2]  Thomas Straube,et al.  Effects of cognitive-behavioral therapy on brain activation in specific phobia , 2006, NeuroImage.

[3]  John D E Gabrieli,et al.  Control over brain activation and pain learned by using real-time functional MRI. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  U. Hegerl,et al.  SERT and DAT availabilities under citalopram treatment in obsessive–compulsive disorder (OCD) , 2005, European Neuropsychopharmacology.

[5]  T. Yoshiura,et al.  Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: A functional magnetic resonance imaging study , 2005, Biological Psychiatry.

[6]  E. Miller,et al.  Different time courses of learning-related activity in the prefrontal cortex and striatum , 2005, Nature.

[7]  I. Podreka,et al.  β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo , 2005, Journal of Neural Transmission / General Section JNT.

[8]  E. Formisano,et al.  Functional connectivity as revealed by spatial independent component analysis of fMRI measurements during rest , 2004, Human brain mapping.

[9]  Sylvain Houle,et al.  Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. , 2004, The American journal of psychiatry.

[10]  P. Szeszko,et al.  Amygdala Volume Reductions in Pediatric Patients with Obsessive–Compulsive Disorder Treated with Paroxetine: Preliminary Findings , 2004, Neuropsychopharmacology.

[11]  F. Woermann,et al.  Posttraumatic stress disorder and fMRI activation patterns of traumatic memory in patients with borderline personality disorder , 2004, Biological Psychiatry.

[12]  Darin D Dougherty,et al.  Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. , 2004, Archives of general psychiatry.

[13]  Gary H. Glover,et al.  Learned regulation of spatially localized brain activation using real-time fMRI , 2004, NeuroImage.

[14]  E. Nestler,et al.  Neurobiology of mental illness, 2nd ed. , 2004 .

[15]  Mark Lau,et al.  Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. , 2004, Archives of general psychiatry.

[16]  Rainer Goebel,et al.  Investigating directed cortical interactions in time-resolved fMRI data using vector autoregressive modeling and Granger causality mapping. , 2003, Magnetic resonance imaging.

[17]  M. D’Esposito,et al.  Alterations in the BOLD fMRI signal with ageing and disease: a challenge for neuroimaging , 2003, Nature Reviews Neuroscience.

[18]  T. Hendler,et al.  Brain reactivity to specific symptom provocation indicates prospective therapeutic outcome in OCD , 2003, Psychiatry Research: Neuroimaging.

[19]  M. Iwakiri,et al.  Effects of behavior therapy on regional cerebral blood flow in obsessive–compulsive disorder , 2003, Psychiatry Research: Neuroimaging.

[20]  M. Bradley,et al.  Brain activation by disgust-inducing pictures in obsessive-compulsive disorder , 2003, Biological Psychiatry.

[21]  Thomas Straube,et al.  Brain activation to phobia-related pictures in spider phobic humans: an event-related functional magnetic resonance imaging study , 2003, Neuroscience Letters.

[22]  E. Stern,et al.  The Emerging Dialogue Between Psychoanalysis and Neuroscience: Neuroimaging Perspectives , 2003, Journal of the American Psychoanalytic Association.

[23]  Y. Sheline.  Neuroimaging studies of mood disorder effects on the brain , 2003, Biological Psychiatry.

[24]  Michael Erb,et al.  Physiological self-regulation of regional brain activity using real-time functional magnetic resonance imaging (fMRI): methodology and exemplary data , 2003, NeuroImage.

[25]  Steven C. R. Williams,et al.  Neural correlates of anxiety associated with obsessive-compulsive symptom dimensions in normal volunteers , 2003, Biological Psychiatry.

[26]  Matthew L. Ho,et al.  Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. , 2003, The American journal of psychiatry.

[27]  Johanne Lévesque,et al.  “Change the mind and you change the brain”: effects of cognitive-behavioral therapy on the neural correlates of spider phobia , 2003, NeuroImage.

[28]  D. Linden.  Cerebral Mechanisms of Learning Revealed by Functional Neuroimaging in Humans , 2003 .

[29]  F. Woermann,et al.  Different fMRI activation patterns of traumatic memory in Borderline personality disorder with and without additional posttraumatic stress disorder , 2003 .

[30]  Michael M. Richter,et al.  Adaptivity and Learning - An Interdisciplinary Debate , 2003 .

[31]  Marc Laruelle,et al.  The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development , 2002, European Neuropsychopharmacology.

[32]  Gregory G. Brown,et al.  Increased amygdala activation to angry and contemptuous faces in generalized social phobia. , 2002, Archives of general psychiatry.

[33]  R. V. Van Heertum,et al.  Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with [11C]McN 5652 , 2002, Psychopharmacology.

[34]  Francisco Lomeña,et al.  Normalization of Frontal Cerebral Perfusion in Remitted Elderly Major Depression: A 12-Month Follow-Up SPECT Study , 2002, NeuroImage.

[35]  P. Jerabek,et al.  The functional neuroanatomy of the placebo effect. , 2002, The American journal of psychiatry.

[36]  T. Furmark,et al.  Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. , 2002, Archives of general psychiatry.

[37]  M. Thase,et al.  Can’t shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals , 2002, Biological Psychiatry.

[38]  Mats Fredrikson,et al.  Neurofunctional correlates of posttraumatic stress disorder: a PET symptom provocation study , 2000, NeuroImage.

[39]  Simon R. Cherry,et al.  18 – Imaging Brain Function with Positron Emission Tomography , 2002 .

[40]  Alan A. Wilson,et al.  Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. , 2001, The American journal of psychiatry.

[41]  M. Mintun,et al.  Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study , 2001, Biological Psychiatry.

[42]  John E. Cooper,et al.  Diagnostic and Statistical Manual of Mental Disorders (4th edn, text revision) (DSM-IV-TR) , 2001, British Journal of Psychiatry.

[43]  M E Phelps,et al.  Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. , 2001, Archives of general psychiatry.

[44]  M. Thase.  Neuroimaging profiles and the differential therapies of depression. , 2001, Archives of general psychiatry.

[45]  Robert L. Royall,et al.  Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. , 2001, Archives of general psychiatry.

[46]  M. Bushnell,et al.  Cortical representation of the sensory dimension of pain. , 2001, Journal of neurophysiology.

[47]  S. Rauch,et al.  Probing striato-thalamic function in obsessive-compulsive disorder and Tourette syndrome using neuroimaging methods. , 2001, Advances in neurology.

[48]  J. Hietala,et al.  PET studies of brain monoamine transporters. , 2000, Current pharmaceutical design.

[49]  W. Drevets.  Neuroimaging studies of mood disorders , 2000, Biological Psychiatry.

[50]  M. Keshavan,et al.  Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. , 2000, Archives of general psychiatry.

[51]  S. Southwick,et al.  Neural correlates of memories of childhood sexual abuse in women with and without posttraumatic stress disorder. , 1999, The American journal of psychiatry.

[52]  M. Bushnell,et al.  Dissociation of sensory and affective dimensions of pain using hypnotic modulation , 1999, Pain.

[53]  L. Parsons,et al.  Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. , 1999, The American journal of psychiatry.

[54]  E. Kandel,et al.  Biology and the future of psychoanalysis: a new intellectual framework for psychiatry revisited. , 1999, The American journal of psychiatry.

[55]  H. Flor,et al.  A spelling device for the paralysed , 1999, Nature.

[56]  W. Singer,et al.  Activation of Heschl’s Gyrus during Auditory Hallucinations , 1999, Neuron.

[57]  T. Paus,et al.  Cerebral Mechanisms of Hypnotic Induction and Suggestion , 1999, Journal of Cognitive Neuroscience.

[58]  Michael E Phelps,et al.  FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder , 1998, Psychiatry Research: Neuroimaging.

[59]  E. Stip,et al.  The functional neuroanatomy of major depression: an fMRI study using an emotional activation paradigm , 1998, Neuroreport.

[60]  B. Sharf,et al.  Risperidone-induced rabbit syndrome , 1998, British Journal of Psychiatry.

[61]  Jeffrey M. Schwartz,et al.  Neuroanatomical aspects of cognitive-behavioural therapy response in obsessive-compulsive disorder , 1998, British Journal of Psychiatry.

[62]  A L Brody,et al.  Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder , 1998, British Journal of Psychiatry.

[63]  U Klose,et al.  fMRI reveals amygdala activation to human faces in social phobics , 1998, Neuroreport.

[64]  M. Bushnell,et al.  Pain affect encoded in human anterior cingulate but not somatosensory cortex. , 1997, Science.

[65]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[66]  J. R. Baker,et al.  Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. , 1996, Archives of general psychiatry.

[67]  Klaus P. Ebmeier,et al.  The role of the cingulate gyrus in depression: From functional anatomy to neurochemistry , 1996, Biological Psychiatry.

[68]  N. Alpert,et al.  A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. , 1996, Archives of general psychiatry.

[69]  M E Phelps,et al.  Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. , 1996, Archives of general psychiatry.

[70]  L. Baer.  Behavior therapy: endogenous serotonin therapy? , 1996, The Journal of clinical psychiatry.

[71]  N. Alpert,et al.  A positron emission tomographic study of simple phobic symptom provocation. , 1995, Archives of general psychiatry.

[72]  Herbert Feistel,et al.  Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation—preliminary results , 1994, Biological Psychiatry.

[73]  C D Frith,et al.  Functional Anatomy of Obsessive–Compulsive Phenomena , 1994, British Journal of Psychiatry.

[74]  N. Alpert,et al.  Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. , 1994, Archives of general psychiatry.

[75]  J. Mazziotta,et al.  Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. , 1992, Archives of general psychiatry.